跳至主要内容
临床试验/ISRCTN28898435
ISRCTN28898435
已完成
不适用

Does fluid administration in the terminally ill reduce the frequency and amount of sedation required for the management of agitation/restlessness?

HS R&D Regional Programme Register - Department of Health (UK)0 个研究点目标入组 0 人2004年1月23日

概览

阶段
不适用
干预措施
未指定
疾病 / 适应症
Symptoms and general pathology
发起方
HS R&D Regional Programme Register - Department of Health (UK)
状态
已完成
最后更新
11年前

概览

简要总结

暂无简介。

注册库
who.int
开始日期
2004年1月23日
结束日期
待定
最后更新
11年前
研究类型
Interventional
性别
All

研究者

发起方
HS R&D Regional Programme Register - Department of Health (UK)

入排标准

入选标准

  • Patients who meet the inclusion criteria will be identified during the daily team meetings held within each of the hospices. The inclusion criteria are as follows:
  • 1\. Deemed to have a short life expectancy (Bozetti 1996\)
  • 2\. Aged above 18
  • 3\. Inpatient within Butterick Hospice, Teesside Hospice, Hartlepool Hospice, St Oswalds Hospice or the Newcastle Marie Curie Centre
  • 4\. Oral intake has fallen below 1000 ml/24 hour and is recognised by the team as part of their deterioration

排除标准

  • 1\. Known to have cerebral oedema
  • 2\. Known to have congestive cardiac failure
  • 3\. Known to have a coagulation disorder
  • 4\. Known to be in renal or liver failure or are hypercalcaemic
  • 5\. Known to have a tumour which has a direct influence on fluid balance

结局指标

主要结局

未指定

相似试验